M.MoadelT.SistiA
The known risks associated with these medicines are reflected in their FDA-approved product labeling which, collectively, FDA has reviewed more than 40 times and are discussed in textbooks, treatment guidelines and journals. Novo Nordisk updates product labels in cooperation with the FDA and consistent with federal regulations to reflect the most current understanding of the safety and efficacy profile of our medicines, said Flavia Brakling, a spokesperson for the company
Oral GLP-1 therapies activate GLP-1 receptors to boost insulin secretion, slow gastric emptying, and reduce appetite, leading to weight loss and improved glucose control
Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, et al
Tell your Found provider about all prescription medications, over-the-counter drugs, vitamins, and supplements you take before starting
Bohn B, Herbst A, Pfeifer M et al (2015) Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients